|
1
|
Cui FB, Huang DF, Zhang FL, Gao EY, Zhang
Y, Cao YM, Ding S, Wang Y, Cao QS and Cao XM: Investigation on the
regulatory effect of PGE2 on ESCC cells through the
trans-activation of EGFR by EP2 and the relevant mechanism. Eur Rev
Med Pharmacol Sci. 21:5668–5676. 2017.PubMed/NCBI
|
|
2
|
Asting AG, Iresjö BM, Nilsberth C, Smedh U
and Lundholm K: Host knockout of E-prostanoid 2 receptors reduces
tumor growth and causes major alterations of gene expression in
prostaglandin E2-producing tumors. Oncol Lett. 13:476–482. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Flórez-Grau G, Cabezón R, Borgman KJE,
España C, Lozano JJ, Garcia-Parajo MF and Benitez-Ribas D:
Up-regulation of EP2 and EP3 receptors in human tolerogenic
dendritic cells boosts the immunosuppressive activity of PGE2. J
Leukoc Biol. 102:881–895. 2017. View Article : Google Scholar
|
|
4
|
Maric J, Ravindran A, Mazzurana L,
Björklund ÅK, Van Acker A, Rao A, Friberg D, Dahlén SE, Heinemann
A, Konya V and Mjösberg J: Prostaglandin E2 suppresses human group
2 innate lymphoid cell function. J Allergy Clin Immunol.
141:1761–1773. 2018. View Article : Google Scholar :
|
|
5
|
Hsu HH, Lin YM, Shen CY, Shibu MA, Li SY,
Chang SH, Lin CC, Chen RJ, Viswanadha VP, Shih HN and Huang CY:
Prostaglandin E2-induced COX-2 expressions via EP2 and EP4
signaling pathways in human LoVo colon cancer cells. Int J Mol Sci.
18:pii: E1132. 2017. View Article : Google Scholar
|
|
6
|
Gong WH, Zhao N, Zhang ZM, Zhang YX, Yan L
and Li JB: The inhibitory effect of resveratrol on COX-2 expression
in human colorectal cancer: A promising therapeutic strategy. Eur
Rev Med Pharmacol Sci. 21:1136–1143. 2017.PubMed/NCBI
|
|
7
|
Wehbi VL and Taskén K: Molecular
mechanisms for cAMP-mediated immunoregulation in t cells-role of
anchored protein kinase a signaling units. Front Immunol.
7:2222016. View Article : Google Scholar
|
|
8
|
Shishikura K, Horiuchi T, Sakata N, Trinh
DA, Shirakawa R, Kimura T, Asada Y and Horiuchi H: Prostaglandin E2
inhibits neutrophil extracellular trap formation through production
of cyclic AMP. Br J Pharmacol. 173:319–331. 2016. View Article : Google Scholar
|
|
9
|
Lee SE, Lim C, Kim H and Cho S: A study of
the anti-inflammatory effects of the ethyl acetate fraction of the
methanol extract of forsythiae fructus. Afr J Tradit Complement
Altern Med. 13:102–113. 2016.
|
|
10
|
Xu L, Stevens J, Hilton MB, Seaman S,
Conrads TP, Veenstra TD, Logsdon D, Morris H, Swing DA, Patel NL,
et al: COX-2 inhibition potentiates antiangiogenic cancer therapy
and prevents metastasis in preclinical models. Sci Transl Med.
6:242ra2842014. View Article : Google Scholar
|
|
11
|
Al-Taei S, Salimu J, Spary LK, Clayton A,
Lester JF and Tabi Z: Prostaglandin E2-mediated
adenosinergic effects on CD14+ cells: Self-amplifying
immunosuppression in cancer. Oncoimmunology. 6:e12683082016.
View Article : Google Scholar
|
|
12
|
Fan Y, Wang Y and Wang K: Prostaglandin E2
stimulates normal bronchial epithelial cell growth through
induction of c-Jun and PDK1, a kinase implicated in oncogenesis.
Respir Res. 16:1492015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Callaghan G and Houston A: Prostaglandin
E2 and the EP receptors in malignancy: Possible therapeutic
targets? Br J Pharmacol. 172:5239–5250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuo KT, Wang HW, Chou TY, Hsu WH, Hsu HS,
Lin CH and Wang LS: Prognostic role of PGE2 receptor EP2 in
esophageal squamous cell carcinoma. Ann Surg Oncol. 16:352–360.
2009. View Article : Google Scholar
|
|
15
|
Edwards TL, Shrubsole MJ, Cai Q, Li G, Dai
Q, Rex DK, Ulbright TM, Fu Z, Murff HJ, Smalley W, et al: A study
of prostaglandin pathway genes and interactions with current
nonsteroidal anti-inflammatory drug use in colorectal adenoma.
Cancer Prev Res (Phila). 5:855–863. 2012. View Article : Google Scholar
|
|
16
|
Tian M and Schiemann WP: PGE2 receptor EP2
mediates the antagonistic effect of COX-2 on TGF-beta signaling
during mammary tumorigenesis. FASEB J. 24:1105–1116. 2010.
View Article : Google Scholar :
|
|
17
|
Yu L, Wu WK, Li ZJ, Li HT, Wu YC and Cho
CH: Prostaglandin E(2) promotes cell proliferation via protein
kinase C/extracellular signal regulated kinase pathway-dependent
induction of c-Myc expression in human esophageal squamous cell
carcinoma cells. Int J Cancer. 125:2540–2546. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Trzaskowski B, Latek D, Yuan S,
Ghoshdastider U, Debinski A and Filipek S: Action of molecular
switches in GPCRs - theoretical and experimental studies. Curr Med
Chem. 19:1090–1109. 2012. View Article : Google Scholar :
|
|
19
|
King N, Hittinger CT and Carroll SB:
Evolution of key cell signaling and adhesion protein families
predates animal origins. Science. 301:361–363. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Ahn S, Kahsai AW, Meng KC,
Latorraca NR, Pani B, Venkatakrishnan AJ, Masoudi A, Weis WI, Dror
RO, et al: Mechanism of intracellular allosteric β2AR antagonist
revealed by X-ray crystal structure. Nature. 548:480–484. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Engelhardt S and Rochais F: G proteins:
More than transducers of receptor-generated signals? Circ Res.
100:1109–1111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gilman AG: G proteins: Transducers of
receptor-generated signals. Annu Rev Biochem. 56:615–649. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kinoshita A, Higashino M, Yoshida K,
Aratani Y, Kakuuchi A, Hanada K, Takeda H, Naganawa A, Matsuya H
and Ohmoto K: Synthesis and evaluation of a potent, well-balanced
EP2/EP3 dual agonist. Bioorg Med Chem. 26:200–214. 2018. View Article : Google Scholar
|
|
24
|
Wang J, Zhang L, Kang D, Yang D and Tang
Y: Activation of PGE2/EP2 and PGE2/EP4 signaling pathways
positively regulate the level of PD-1 in infiltrating
CD8+ T cells in patients with lung cancer. Oncol Lett.
15:552–558. 2018.
|
|
25
|
Ota H, Katanosaka K, Murase S, Furuyashiki
T, Narumiya S and Mizumura K: EP2 receptor plays pivotal roles in
generating mechanical hyperalgesia after lengthening contractions.
Scand J Med Sci Sports. 28:826–833. 2018. View Article : Google Scholar
|
|
26
|
Wang S, Xie L, Zhang Y, Xu P and Liu A:
Expression of prostaglandin E2 receptors in acquired
middle ear cholesteatoma. Clin Exp Otorhinolaryngol. 11:17–22.
2018. View Article : Google Scholar
|
|
27
|
Dinç E, Dursun Ö, Yilmaz B, Vatansever M,
Sari AA, Yıldırım Ö and Adıgüzel U: Expression of prostaglandin E2
receptor subtypes in human pterygium and normal conjunctiva:
Immunohistochemical study. Int Ophthalmol. Jul 10–2017.Epub ahead
of print.
|
|
28
|
Yu Y and Chadee K: Prostaglandin E2
stimulates IL-8 gene expression in human colonic epithelial cells
by a posttranscriptional mechanism. J Immunol. 161:3746–3752.
1998.PubMed/NCBI
|
|
29
|
Nakayama T, Mutsuga N, Yao L and Tosato G:
Prostaglandin E2 promotes degranulation-independent release of
MCP-1 from mast cells. J Leukoc Biol. 79:95–104. 2006. View Article : Google Scholar
|
|
30
|
Weller CL, Collington SJ, Hartnell A,
Conroy DM, Kaise T, Barker JE, Wilson MS, Taylor GW, Jose PJ and
Williams TJ: Chemotactic action of prostaglandin E2 on mouse mast
cells acting via the PGE2 receptor 3. Proc Natl Acad Sci USA.
104:11712–11717. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Margeta-Mitrovic M, Jan YN and Jan LY: A
trafficking checkpoint controls GABA(B) receptor
heterodimerization. Neuron. 27:97–106. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Malty RH, Hudmon A, Fehrenbacher JC and
Vasko MR: Long-term exposure to PGE2 causes homologous
desensitization of receptor-mediated activation of protein kinase
A. J Neuroinflammation. 13:1812016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shibuya I, Setiadji SV, Ibrahim N,
Harayama N, Maruyama T, Ueta Y and Yamashita H: Involvement of
postsynaptic EP4 and presynaptic EP3 receptors in actions of
prostaglandin E2 in rat supraoptic neurones. J Neuroendocrinol.
14:64–72. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Su Y, Jackson EK and Gorelik E: Receptor
desensitization and blockade of the suppressive effects of
prostaglandin E(2) and adenosine on the cytotoxic activity of human
melanoma-infiltrating T lymphocytes. Cancer Immunol Immunother.
60:111–122. 2011. View Article : Google Scholar
|
|
35
|
Aoki T and Narumiya S: Prostaglandin
E2-EP2 signaling as a node of chronic inflammation in
the colon tumor microenvironment. Inflamm Regen. 37:42017.
View Article : Google Scholar
|
|
36
|
Salinas-Parra N, Reyes-Martinez C, Prieto
MC and Gonzalez AA: Prostaglandin E2 induces prorenin-dependent
activation of (Pro) renin receptor and upregulation of
cyclooxygenase-2 in collecting duct cells. Am J Med Sci.
354:310–318. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Byun JY, Youn YS, Lee YJ, Choi YH, Woo SY
and Kang JL: Interaction of apoptotic cells with macrophages
upregulates COX-2/PGE2 and HGF expression via a positive feedback
loop. Mediators Inflamm. 2014:4635242014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Baba Y, Nosho K, Shima K, Goessling W,
Chan AT, Ng K, Chan JA, Giovannucci EL, Fuchs CS and Ogino S:
PTGER2 overexpression in colorectal cancer is associated with
microsatellite instability, independent of CpG island methylator
phenotype. Cancer Epidemiol Biomarkers Prev. 19:822–831. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Castellone MD, Teramoto H, Williams BO,
Druey KM and Gutkind JS: Prostaglandin E2 promotes colon cancer
cell growth through a Gs-axin-beta-catenin signaling axis. Science.
310:1504–1510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hsu HH, Chen MC, Day CH, Lin YM, Li SY, Tu
CC, Padma VV, Shih HN, Kuo WW and Huang CY: Thymoquinone suppresses
migration of LoVo human colon cancer cells by reducing
prostaglandin E2 induced COX-2 activation. World J Gastroenterol.
23:1171–1179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lian S, Xia Y, Ung TT, Khoi PN, Yoon HJ,
Lee SG, Kim KK and Jung YD: Prostaglandin E2 stimulates
urokinase-type plasminogen activator receptor via EP2
receptor-dependent signaling pathways in human AGS gastric cancer
cells. Mol Carcinog. 56:664–680. 2017. View Article : Google Scholar
|
|
42
|
Merz C, von Mässenhausen A, Queisser A,
Vogel W, Andrén O, Kirfel J, Duensing S, Perner S and Nowak M: IL-6
overexpression in ERG-positive prostate cancer is mediated by
prostaglandin receptor EP2. Am J Pathol. 186:974–984. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zang S, Ma X, Wu Y, Liu W, Cheng H, Li J,
Liu J and Huang A: PGE2 synthesis and signaling in malignant
transformation and progression of human hepatocellular carcinoma.
Hum Pathol. 63:120–127. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Koh SJ, Kim JM, Kim IK, Ko SH and Kim JS:
Anti-inflammatory mechanism of metformin and its effects in
intestinal inflammation and colitis-associated colon cancer. J
Gastroenterol Hepatol. 29:502–510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bonfill-Teixidor E, Otxoa-de-Amezaga A,
Font-Nieves M, Sans-Fons MG and Planas AM: Differential expression
of E-type prostanoid receptors 2 and 4 in microglia stimulated with
lipopolysaccharide. J Neuroinflammation. 14:32017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Huynh K: Inflammation: Targeting
inflammatory pathways to treat atherosclerosis and cancer. Nat Rev
Cardiol. 14:6292017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu Y, Fang S, Li X, Feng J, Du J, Guo L,
Su Y, Zhou J, Ding G, Bai Y, et al: Aspirin inhibits LPS-induced
macrophage activation via the NF-κB pathway. Sci Rep. 7:115492017.
View Article : Google Scholar
|
|
48
|
Kang X, Qiu J, Li Q, Bell KA, Du Y, Jung
DW, Lee JY, Hao J and Jiang J: Cyclooxygenase-2 contributes to
oxidopamine-mediated neuronal inflammation and injury via the
prostaglandin E2 receptor EP2 subtype. Sci Rep. 7:94592017.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gill SK, Yao Y, Kay LJ, Bewley MA,
Marriott HM and Peachell PT: The anti-inflammatory effects of PGE2
on human lung macrophages are mediated by the EP4 receptor. Br J
Pharmacol. 173:3099–3109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kawahara K, Hohjoh H, Inazumi T, Tsuchiya
S and Sugimoto Y: Prostaglandin E2-induced inflammation: Relevance
of prostaglandin E receptors. Biochim Biophys Acta. 1851:414–421.
2015. View Article : Google Scholar
|
|
51
|
Jiang J, Quan Y, Ganesh T, Pouliot WA,
Dudek FE and Dingledine R: Inhibition of the prostaglandin receptor
EP2 following status epilepticus reduces delayed mortality and
brain inflammation. Proc Natl Acad Sci USA. 110:3591–3596. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hooper KM, Yen JH, Kong W, Rahbari KM, Kuo
PC, Gamero AM and Ganea D: Prostaglandin E2 Inhibition of IL-27
Production in Murine Dendritic Cells: A novel mechanism that
involves IRF1. J Immunol. 198:1521–1530. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li S, Xu X, Jiang M, Bi Y, Xu J and Han M:
Lipopolysaccharide induces inflammation and facilitates lung
metastasis in a breast cancer model via the prostaglandin E2-EP2
pathway. Mol Med Rep. 11:4454–4462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li X, Su Y, Hua X, Xie C, Liu J, Huang Y,
Zhou L, Zhang M, Li X and Gao Z: Levels of hepatic Th17 cells and
regulatory T cells upregulated by hepatic stellate cells in
advanced HBV-related liver fibrosis. J Transl Med. 15:752017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fennekohl A, Lucas M and Püschel GP:
Induction by interleukin 6 of G(s)-coupled prostaglandin E(2)
receptors in rat hepatocytes mediating a prostaglandin
E(2)-dependent inhibition of the hepatocyte's acute phase response.
Hepatology. 31:1128–1134. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kabashima K, Nagamachi M, Honda T,
Nishigori C, Miyachi Y, Tokura Y and Narumiya S: Prostaglandin E2
is required for ultraviolet B-induced skin inflammation via EP2 and
EP4 receptors. Lab Invest. 87:49–55. 2007. View Article : Google Scholar
|
|
57
|
Prasad R and Katiyar SK: Ultraviolet
radiation-induced inflammation activates β-catenin signaling in
mouse skin and skin tumors. Int J Oncol. 44:1199–1206. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Prasad R and Katiyar SK: Prostaglandin E2
Promotes UV radiation-induced immune suppression through DNA
hyper-methylation. Neoplasia. 15:795–804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ma X, Aoki T, Tsuruyama T and Narumiya S:
Definition of prostaglandin E2-EP2 signals in the colon tumor
microenvironment that amplify inflammation and tumor growth. Cancer
Res. 75:2822–2832. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shehzad A, Ul Islam S, Lee J and Lee YS:
Prostaglandin E2 reverses curcumin-induced inhibition of survival
signal pathways in human colorectal carcinoma (HCT-15) cell lines.
Mol Cells. 37:899–906. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang D, Huang S, Yuan X, Liang J, Xu R,
Yao G, Feng X and Sun L: The regulation of the Treg/Th17 balance by
mesenchymal stem cells in human systemic lupus erythematosus. Cell
Mol Immunol. 14:423–431. 2017. View Article : Google Scholar :
|
|
62
|
Lejeune M, Moreau F and Chadee K: Loss of
EP2 receptor subtype in colonic cells compromise epithelial barrier
integrity by altering claudin-4. PLos One. 9:e1132702014.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Trésfier A, Musnier A, Landomiel F,
Bourquard T, Boulo T, Ayoub MA, León K, Bruneau G, Chevalier M,
Durand G, et al: G protein-dependent signaling triggers a
β-arrestin-scaffolded p70S6K/rpS6 module that controls 5'TOP mRNA
translation. FASEB J. 32:1154–1169. 2018. View Article : Google Scholar
|
|
64
|
Kaul V, Bhattacharya D, Singh Y, Van Kaer
L, Peters-Golden M, Bishai WR and Das G: An important role of
prostanoid receptor EP2 in host resistance to Mycobacterium
tuberculosis infection in mice. J Infect Dis. 206:1816–1825. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Qian X, Zhang J and Liu J: Tumor-secreted
PGE2 inhibits CCL5 production in activated macrophages through
cAMP/PKA signaling pathway. J Biol Chem. 286:2111–2120. 2011.
View Article : Google Scholar :
|
|
66
|
Leander R and Friedman A: Modulation of
the cAMP response by Gαi and Gβγ: A computational study of G
protein signaling in immune cells. Bull Math Biol. 76:1352–1375.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sreeramkumar V, Hons M, Punzón C, Stein
JV, Sancho D, Fresno M and Cuesta N: Efficient T-cell priming and
activation requires signaling through prostaglandin E2 (EP)
receptors. Immunol Cell Biol. 94:39–51. 2016. View Article : Google Scholar
|
|
68
|
Mao Y, Sarhan D, Steven A, Seliger B,
Kiessling R and Lundqvist A: Inhibition of tumor-derived
prostaglandin-e2 blocks the induction of myeloid-derived suppressor
cells and recovers natural killer cell activity. Clin Cancer Res.
20:4096–4106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yang L, Yamagata N, Yadav R, Brandon S,
Courtney RL, Morrow JD, Shyr Y, Boothby M, Joyce S, Carbone DP and
Breyer RM: Cancer-associated immunodeficiency and dendritic cell
abnormalities mediated by the prostaglandin EP2 receptor. J Clin
Invest. 111:727–735. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Marin-Acevedo JA, Soyano AE, Dholaria B,
Knutson KL and Lou Y: Cancer immunotherapy beyond immune checkpoint
inhibitors. J Hematol Oncol. 11:82018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Fujimoto Y, Iwagaki H, Ozaki M, Ogino T,
Murata H, Sun DS, Sadamori H, Takahashi HK, Tanaka N and Yagi T:
Involvement of prostaglandin receptors (EPR2-4) in in vivo
immunosuppression of PGE2 in rat skin transplant model. Int
Immunopharmacol. 5:1131–1139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bonanno A, Albano GD, Siena L, Montalbano
AM, Riccobono L, Anzalone G, Chiappara G, Gagliardo R, Profita M
and Sala A: Prostaglandin E2 possesses different
potencies in inducing Vascular Endothelial Growth Factor and
Interleukin-8 production in COPD human lung fibroblasts.
Prostaglandins Leukot Essent Fatty Acids. 106:11–18. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wiktorowska-Owczarek A and Owczarek J: The
effect of hypoxia on PGE2-stimulated cAMP generation in HMEC-1.
Cell Mol Biol Lett. 20:213–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Aoyagi T, Newstead MW, Zeng X, Nanjo Y,
Peters-Golden M, Kaku M and Standiford TJ: Interleukin-36γ and
IL-36 receptor signaling mediate impaired host immunity and lung
injury in cytotoxic Pseudomonas aeruginosa pulmonary infection:
Role of prostaglandin E2. PLos Pathog. 13:e10067372017. View Article : Google Scholar
|
|
75
|
Takahashi T, Uehara H and Izumi K:
Inhibitory effect of soluble EP2 receptor on ovarian tumor growth
in nude mice and utility of TMPRSS4 as a combinatorial molecular
target. Int J Oncol. 43:416–424. 2013.PubMed/NCBI
|
|
76
|
Cheng SY, Zhang H, Zhang M, Xia SK, Bai
XM, Zhang L, Ma J, Rong R, Wang YP, Du MZ, et al: Prostaglandin
E2 receptor EP2 mediates Snail expression in
hepatocellular carcinoma cells. Oncol Rep. 31:2099–2106. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Sobhani N, Roviello G, Corona SP,
Scaltriti M, Ianza A, Bortul M, Zanconati F and Generali D: The
prognostic value of PI3K mutational status in breast cancer: A
meta-analysis. J Cell Biochem. 119:4287–4292. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ma W and St-Jacques B: Signalling
transduction events involved in agonist-induced PGE2/EP4 receptor
externalization in cultured rat dorsal root ganglion neurons. Eur J
Pain. 22:845–861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Regan JW: EP2 and EP4 prostanoid receptor
signaling. Life Sci. 74:143–153. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Allison SE, Petrovic N, Mackenzie PI and
Murray M: Pro-migratory actions of the prostacyclin receptor in
human breast cancer cells that overexpress cyclooxygenase-2.
Biochem Pharmacol. 96:306–314. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Cheuk IW, Shin VY, Siu MT, Tsang JY, Ho
JC, Chen J, Tse GM, Wang X and Kwong A: Association of EP2 receptor
and SLC19A3 in regulating breast cancer metastasis. Am J Cancer
Res. 5:3389–3399. 2015.
|
|
82
|
Kim KM, Im AR, Kim SH, Hyun JW and Chae S:
Timosaponin AIII inhibits melanoma cell migration by suppressing
COX-2 and in vivo tumor metastasis. Cancer Sci. 107:181–188. 2016.
View Article : Google Scholar :
|
|
83
|
Rundhaug JE, Simper MS, Surh I and Fischer
SM: The role of the EP receptors for prostaglandin E2 in skin and
skin cancer. Cancer Metastasis Rev. 30:465–480. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Rundhaug JE and Fischer SM:
Cyclo-oxygenase-2 plays a critical role in UV-induced skin
carcinogenesis. Photochem Photobiol. 84:322–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Singh T, Vaid M, Katiyar N, Sharma S and
Katiyar SK: Berberine, an isoquinoline alkaloid, inhibits melanoma
cancer cell migration by reducing the expressions of
cyclo-oxygenase-2, prostaglandin E2 and prostaglandin
E2 receptors. Carcinogenesis. 32:86–92. 2011. View Article : Google Scholar
|
|
86
|
Mochocki M, Morawski P, Kopta R,
Brzezinska-Blaszczyk E, Stasikowska O, Lewy-Trenda I; Student
Scientific Circle; Starska K: Expression of prostaglandin E2
prostanoid receptor EP2 and interleukin-1β in laryngeal
carcinoma-preliminary study. Contemp Oncol (Pozn). 19:113–119.
2015.
|
|
87
|
Cantaut-Belarif Y, Antri M, Pizzarelli R,
Colasse S, Vaccari I, Soares S, Renner M, Dallel R, Triller A and
Bessis A: Microglia control the glycinergic but not the GABAergic
synapses via prostaglandin E2 in the spinal cord. J Cell Biol.
216:2979–2989. 2017.PubMed/NCBI
|
|
88
|
de Almeida VH, de Melo AC, Meira DD, Pires
AC, Nogueira-Rodrigues A, Pimenta-Inada HK, Alves FG, Moralez G,
Thiago LS, Ferreira CG and Sternberg C: Radiotherapy modulates
expression of EGFR, ERCC1 and p53 in cervical cancer. Braz J Med
Biol Res. 51:e68222017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ochoa MC, Minute L, López A4, Pérez-Ruiz
E, Gomar C, Vasquez M, Inoges S, Etxeberria I, Rodriguez I, Garasa
S, et al: Enhancement of antibody-dependent cellular cytotoxicity
of cetuximab by a chimeric protein encompassing interleukin-15.
Oncoimmunology. 7:e13935972017. View Article : Google Scholar
|
|
90
|
Chen A, Ali N, Boasberg P and Ho AS:
Clinical remission of cutaneous squamous cell carcinoma of the
auricle with cetuximab and nivolumab. J Clin Med. 7:pii: E10. 2018.
View Article : Google Scholar
|
|
91
|
Fernández-Martínez AB and Lucio-Cazaña J:
Intracellular EP2 prostanoid receptor promotes cancer-related
phenotypes in PC3 cells. Cell Mol Life Sci. 72:3355–3373. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
López Bernal A, Rivera J, Europe-Finner
GN, Phaneuf S and Asbóth G: Parturition: Activation of stimulatory
pathways or loss of uterine quiescence? Adv Exp Med Biol.
395:435–451. 1995.PubMed/NCBI
|
|
93
|
Brocard E, Oizel K, Lalier L, Pecqueur C,
Paris F, Vallette FM and Oliver L: Radiation-induced PGE2 sustains
human glioma cells growth and survival through EGF signaling.
Oncotarget. 6:6840–6849. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Schmidt A, Sinnett-Smith J, Young S, Chang
HH, Hines OJ, Dawson DW, Rozengurt E and Eibl G: Direct
growth-inhibitory effects of prostaglandin E2 in pancreatic cancer
cells in vitro through an EP4/PKA-mediated mechanism. Surgery.
161:1570–1578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Vaid M, Singh T, Prasad R, Kappes JC and
Katiyar SK: Therapeutic intervention of proanthocyanidins on the
migration capacity of melanoma cells is mediated through PGE2
receptors and β-catenin signaling molecules. Am J Cancer Res.
5:3325–3338. 2015.
|
|
96
|
Chang HH, Young SH, Sinnett-Smith J, Chou
CE, Moro A, Hertzer KM, Hines OJ, Rozengurt E and Eibl G:
Prostaglandin E2 activates the mTORC1 pathway through an
EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human
pancreatic carcinoma cell line PANC-1. Am J Physiol Cell Physiol.
309:C639–C649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chun KS, Lao HC, Trempus CS, Okada M and
Langenbach R: The prostaglandin receptor EP2 activates multiple
signaling pathways and beta-arrestin1 complex formation during
mouse skin papilloma development. Carcinogenesis. 30:1620–1627.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Shu J, Zhang F, Zhang L and Wei W: G
protein coupled receptors signaling pathways implicate in
inflammatory and immune response of rheumatoid arthritis. Inflamm
Res. 66:379–387. 2017. View Article : Google Scholar
|
|
99
|
Yun SP, Ryu JM, Jang MW and Han HJ:
Interaction of profilin-1 and F-actin via a β-arrestin-1/JNK
signaling pathway involved in prostaglandin E(2)-induced human
mesenchymal stem cells migration and proliferation. J Cell Physiol.
226:559–571. 2011. View Article : Google Scholar
|
|
100
|
Narumiya S, Sugimoto Y and Ushikubi F:
Prostanoid receptors: Structures, properties, and functions.
Physiol Rev. 79:1193–1226. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Ganesh T: Prostanoid receptor EP2 as a
therapeutic target. J Med Chem. 57:4454–4465. 2014. View Article : Google Scholar :
|
|
102
|
Tani K, Naganawa A, Ishida A, Egashira H,
Sagawa K, Harada H, Ogawa M, Maruyama T, Ohuchida S, Nakai H, et
al: Design and synthesis of a highly selective EP2-receptor
agonist. Bioorg Med Chem Lett. 11:2025–2028. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Jadhav V, Jabre A, Lin SZ and Lee TJ: EP1-
and EP3-receptors mediate prostaglandin E2-induced constriction of
porcine large cerebral arteries. J Cereb Blood Flow Metab.
24:1305–1316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Tani K, Naganawa A, Ishida A, Sagawa K,
Harada H, Ogawa M, Maruyama T, Ohuchida S, Nakai H, Kondo K and
Toda M: Development of a highly selective EP2-receptor agonist.
Part 1: Identification of 16-hydroxy-17, 17-trimethylene PGE2
derivatives. Bioorg Med Chem. 10:1093–1106. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Markovič T, Jakopin Ž, Dolenc MS and
Mlinarič-Raščan I: Structural features of subtype-selective EP
receptor modulators. Drug Discov Today. 22:57–71. 2017. View Article : Google Scholar
|
|
106
|
Yeo HS, Shehzad A and Lee YS:
Prostaglandin E2 blocks menadione-induced apoptosis through the
Ras/Raf/Erk signaling pathway in promonocytic leukemia cell lines.
Mol Cells. 33:371–378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Tanné B, Bernier S and Dumais N: CCR7
receptor expression in Mono-MAC-1 cells: modulation by liver X
receptor α activation and prostaglandin E 2. Int J Inflam.
2015:2015712015. View Article : Google Scholar
|
|
108
|
Takahashi HK, Liu K, Wake H, Mori S, Zhang
J, Liu R, Yoshino T and Nishibori M: Prostaglandin E2 inhibits
advanced glycation end product-induced adhesion molecule
expression, cytokine production, and lymphocyte proliferation in
human peripheral blood mononuclear cells. J Pharmacol Exp Ther.
331:656–670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wang R, Zhang W, Dong Z, Qi Y, Hultström
M, Zhou X and Lai EY: c-Jun N-terminal Kinase mediates
prostaglandin-induced sympathoexcitation in rats with chronic heart
failure by reducing GAD1 and GABRA1 expression. Acta Physiol (Oxf).
219:494–509. 2017. View Article : Google Scholar
|
|
110
|
Cameron KO, Lefker BA, Ke HZ, Li M,
Zawistoski MP, Tjoa CM, Wright AS, DeNinno SL, Paralkar VM, Owen
TA, et al: Discovery of CP-533536: An EP2 receptor selective
prostaglandin E2 (PGE2) agonist that induces local bone formation.
Bioorg Med Chem Lett. 19:2075–2078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Säfholm J, Dahlén SE and Adner M:
Antagonising EP1 and EP2 receptors reveal that the TP receptor
mediates a component of antigen-induced contraction of the guinea
pig trachea. Eur J Pharmacol. 718:277–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Yan G, Wang Q, Shi H, Han Y, Ma G, Tang C
and Gu Y: Regulation of rat intrapulmonary arterial tone by
arachidonic acid and prostaglandin E2 during hypoxia. PLoS One.
8:e738392013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Kay LJ, Gilbert M, Pullen N, Skerratt S,
Farrington J, Seward EP and Peachell PT: Characterization of the EP
receptor subtype that mediates the inhibitory effects of
prostaglandin E2 on IgE-dependent secretion from human lung mast
cells. Clin Exp Allergy. 43:741–751. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
af Forselles KJ, Root J, Clarke T, Davey
D, Aughton K, Dack K and Pullen N: In vitro and in vivo
characterization of PF-04418948, a novel, potent and selective
prostaglandin EP2 receptor antagonist. Br J Pharmacol.
164:1847–1856. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45(W1):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
